Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'neuropeptide y 13 36 porcine'

Search results for: 'neuropeptide y 13 36 porcine'

Items 11-20 of 41

Page
per page
  1. Torin 1
    A8312 Torin 1
     7 Citation
    Target: mTOR
    Summary: MTOR inhibitor,potent and selective
  2. LY335979 (Zosuquidar 3HCL)
    A8549 LY335979 (Zosuquidar 3HCL)
     1 Citation
    Target: P-glycoprotein (P-gp)
    Summary: Pgp (P-glycoprotein) inhibitor
      insoluble in EtOH; ≥17.1 mg/mL
  3. Faropenem daloxate
    A3411 Faropenem daloxate
    Summary: Oral penem,beta-lactam antibiotic
      Soluble in DMSO
  4. GSK2606414
    A3448 GSK2606414
     4 Citation
    Summary: PERK inhibitor,potent and selective
      ≥22.57 mg/mL
  5. C646
    B1577 C646
     1 Citation
    Target: p300
    Summary: HAT p300-CBP inhibitor,cell-permeable
      insoluble in H2O; ≥11.14 mg/mL
  6. GM 6001
    A4050 GM 6001
     2 Citation
    Target: MMP
    Summary: Broad spectrum MMP inhibitor
      insoluble in H2O; insoluble in EtOH; ≥19.42 mg/mL
  7. BMS-626529
    A3253 BMS-626529
     2 Citation
    Target: HIV-1 gp120
    Summary: HIV-1 attachment inhibitor
      insoluble in H2O; insoluble in EtOH; ≥1.48 mg/mL
  8. RI-2
    B5881 RI-2
    Target: RAD51
    Summary: Optimized reversible RAD51 inhibitor
      ≥21.65 mg/mL
  9. BRL 50481
    B6988 BRL 50481
    Target: Phosphodiesterases (PDEs)
    Summary: PDE7 inhibitor,potent and selective
      Soluble in DMSO
  10. LRRK2-IN-1
    A3558 LRRK2-IN-1
     1 Citation
    Target: LRRK2|DCLK2
    Summary: LRRK2 inhibitor,cell-permeable and ATP competitive
      ≥28.55 mg/mL

Items 11-20 of 41

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Lab Reagents 1 item
Reversibility
  1. Reversible 3item
Target
  1. Histone Deacetylases (HDACs) 2item
  2. Akt 1 item
  3. PI3K 4item
  4. CXCR 1 item
  5. Raf 2item
  6. Aurora Kinases 2item
  7. mTOR 2item
  8. MMP 3item
  9. Androgen Receptors 1 item
  10. FLT3 2item
  11. LPA Receptors 1 item
  12. P-glycoprotein (P-gp) 1 item
  13. Eph Receptors 1 item
  14. VEGFR 4item
  15. PDGFR 4item
  16. c-Kit 2item
  17. RET 1 item
  18. Phosphodiesterases (PDEs) 1 item
  19. Bcr-Abl 2item
  20. FGFR 2item
  21. Src 1 item
  22. ROCK 1 item
  23. PAK 1 item
  24. p300 1 item
  25. DNA-PK 3item
  26. HSP90 1 item
  27. RAD51 1 item
  28. LRRK2 1 item
  29. Voltage-gated Calcium Channels (CaV) 1 item
  30. Melanocortin (MC) Receptors 1 item
  31. HIV-1 gp120 1 item
  32. Glutamate (Metabotropic) Group I Receptors 1 item
  33. NPY Receptors 1 item
  34. Na /K ATPases 1 item
  35. P110 1 item
  36. Hck 1 item
  37. Catechol O-Methyltransferase (COMT) 1 item
  38. angiogenesis 1 item
  39. DCLK2 1 item
  40. gp120/CD4 1 item
  41. ATM 1 item
Related Disease
  1. Adrenocortical Carcinoma 1 item
  2. Bladder Cancer 1 item
  3. Brain Injuries Studies 1 item
  4. Breast Cancer 4item
  5. Cancer 26item
  6. Chronic Lymphocytic Leukemia 2item
  7. Chronic Myeloproliferative Disorders 1 item
  8. Clear Cell Renal Cell Carcinoma 1 item
  9. Cocaine-Related Disorders 1 item
  10. Colon Cancer 2item
  11. Colorectal Cancer 3item
  12. Glioblastoma 2item
  13. Glioma 3item
  14. HIV 2item
  15. Leukemia 3item
  16. Lung Cancer 2item
  17. Lymphoma 1 item
  18. Melanoma 1 item
  19. Multiple Myeloma 3item
  20. Myelofibrosis 1 item
  21. Neuroblastoma 3item
  22. Neurocognitive Disorders 1 item
  23. Non-small Cell Lung Carcinoma 1 item
  24. Obsessive-Compulsive Disorder 1 item
  25. Osteoporosis 1 item
  26. Ovarian Cancer 2item
  27. Pancreatic Cancer 3item
  28. Prostate Cancer 3item
  29. Pulmonary Fibrosis 1 item
  30. Renal Cancer 1 item
  31. Schizophrenia 1 item
  32. Soft Tissue Sarcoma 1 item
  33. Thyroid Cancer 1 item